PNC FINANCIAL SERVICES GROUP, INC.
Position in GLSI — Greenwich LifeSciences, Inc.
CIK 713676
Pittsburgh, PA
Position in GLSI
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$240
-$117 QoQ
Shares Held
10
-41.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $99,747,802 across 265 Biotechnology names. GLSI ranks #251 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
71,942 | $32,124,978 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,226 | $14,082,131 | |
| 3 | TECH |
BIO-TECHNE Corp
|
93,722 | $4,897,909 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,322 | $4,076,976 | |
| 5 | MRNA |
Moderna, Inc.
|
69,883 | $3,550,054 | |
| 6 | INCY |
Incyte Corp
|
33,976 | $3,197,817 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
37,360 | $3,135,250 | |
| 8 | ARGX |
Argenx SE
|
3,796 | $2,772,027 |
All Filings in GLSI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240 | 10 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $357 | 17 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $288 | 29 | Shares | Defined | 2025-11-07 | |
| 2021-06-30 | $4,494 | 100 | Shares | Defined | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||